| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| BCYRN1 |
|
brain cytoplasmic RNA 1
|
|
|
0.666 |
0.423 |
| EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| RNU1-4 |
|
RNA, U1 small nuclear 4
|
|
|
0.626 |
0.577 |
| SEA |
|
S13 erythroblastosis (avian) oncogene homolog
|
|
|
0.606 |
0.615 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
| TRP-AGG2-5 |
|
tRNA-Pro (anticodon AGG) 2-5
|
|
|
0.722 |
0.423 |
| UGT1A |
|
UDP glucuronosyltransferase family 1 member A complex locus
|
|
|
0.540 |
0.654 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| XRS |
|
X-ray sensitivity
|
|
|
0.716 |
0.500 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| MYLKP1 |
|
myosin light chain kinase pseudogene 1
|
|
|
0.805 |
0.115 |
| KCNQ1OT1 |
|
KCNQ1 opposite strand/antisense transcript 1
|
|
|
0.534 |
0.731 |
| SNHG1 |
|
small nucleolar RNA host gene 1
|
|
|
0.576 |
0.692 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
| MEG3 |
|
maternally expressed 3
|
|
|
0.471 |
0.846 |
| PCDHA@ |
|
protocadherin alpha cluster, complex locus
|
|
|
0.736 |
0.346 |
| BRCA3 |
|
breast cancer 3
|
|
|
0.705 |
0.269 |
| FRTS1 |
|
Fanconi renotubular syndrome
|
|
|
0.599 |
0.654 |